Associations of apolipoprotein E exon 4 and lipoprotein lipase S447X polymorphisms with acute ischemic stroke and myocardial infarction

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 3, 2006, Pages 274-281

  Baum, Larry ^a   Ho, Keung Ng ^a   Ka, Sing Wong ^a   Tomlinson, Brian ^a   Rainer, Timothy Hudson ^a   Chen, Xiangyan ^a   Wing, Sze Cheung ^a   Tang, Jinling ^a   Tam, Wilson Wai San ^a   Goggins, William ^a   Tong, Cindy See Wai ^a   Chan, Daniel Kam Yin ^b   Thomas, G Neil ^c   Chook, Ping ^a   Kam, Sang Woo ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apolipoprotein E; Ischemic; Lipoprotein lipase; Polymorphism; Smoking

Indexed keywords

APOLIPOPROTEIN E; LIPOPROTEIN LIPASE;

ACUTE HEART INFARCTION; ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; EXON; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HOMOZYGOTE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CEREBROVASCULAR ACCIDENT; EXONS; FEMALE; GENOTYPE; HONG KONG; HUMANS; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 33644831718     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.047     Document Type: Article

References (35)

1. Galton DJ, Mattu R, Needham EW, Cavanna J. Identification of putative beneficial mutations for lipid transport. Z Gastroenterol 1996;34(Suppl 3):56-8.
2. Peacock RE, Hamsten A, Nilsson-Ehle P, Humphries SE. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 1992;97:171-85.
3. Gagne SE, Larson MG, Pimstone SN, Schaefer EJ, Kastelein JJ, Wilson PW, et al. A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study. Clin Genet 1999;55:450-4.
4. Reymer PW, Gagne E, Groenemeyer BE, Zhang H, Forsyth I, Jansen H, et al. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat Genet 1995;10:28-34.
5. Wittrup HH, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg-Hansen A. Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study. Atherosclerosis 2002;165:119-26.
6. Mattu RK, Needham EW, Morgan R, Rees A, Hackshaw AK, Stocks J, et al. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler Thromb 1994;14:1090-7.
7. Jemaa R, Fumeron F, Poirier O, Lecerf L, Evans A, Arveiler D, et al. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Temoin sur l'Infarctus du Myocarde. J Lipid Res 1995;36:2141-6.
8. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
9. Kolovou G, Daskalova D, Mikhailidis DP. Apolipoprotein E polymorphism and atherosclerosis. Angiology 2003;54:59-71.
10. Lahoz C, Schaefer EJ, Cupples LA, Wilson PW, Levy D, Osgood D, et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 2001;154:529-37.
11. McCarron MO, Delong D, Alberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology 1999;53:1308-11.
12. Nassar BA, Dunn J, Title LM, O'Neill BJ, Kirkland SA, Zayed E, et al. Relation of genetic polymorphisms of apolipoprotein E, angiotensin converting enzyme, apolipoprotein B-100, and glycoprotein IIIa and early-onset coronary heart disease. Clin Biochem 1999;32:275-82.
13. Shimo-Nakanishi Y, Urabe T, Hattori N, Watanabe Y, Nagao T, Yokochi M, et al. Polymorphism of the lipoprotein lipase gene and risk of atherothrombotic cerebral infarction in the Japanese. Stroke 2001;32:1481-6.
14. Talmud PJ, Stephens JW. Lipoprotein lipase gene variants and the effect of environmental factors on cardiovascular disease risk. Diabetes Obes Metab 2004;6:1-7.
15. Wilson PW, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 1996;16:1250-5.
16. Clee SM, Bissada N, Miao F, Miao L, Marais AD, Henderson HE, et al. Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis. J Lipid Res 2000;41:521-31.
17. Groenemeijer BE, Hallman MD, Reymer PW, Gagne E, Kuivenhoven JA, Bruin T, et al. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. Circulation 1997;95:2628-35.
18. Henderson HE, Kastelein JJ, Zwinderman AH, Gagne E, Jukema JW, Reymer PW, et al. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins. J Lipid Res 1999;40:735-43.
19. Lee J, Tan CS, Chia KS, Tan CE, Chew SK, Ordovas JM, et al. The lipoprotein lipase S447X polymorphism and plasma lipids: interactions with APOE polymorphisms, smoking, and alcohol consumption. J Lipid Res 2004;45:1132-9.
20. Salah D, Bohnet K, Gueguen R, Siest G, Visvikis S. Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort. J Lipid Res 1997;38:904-12.
21. Freeman DJ, Caslake MJ, Griffin BA, Hinnie J, Tan CE, Watson TD, et al. The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma. Eur J Clin Invest 1998;28:584-91.
22. Wilson K, Fry GL, Chappell DA, Sigmund CD, Medh JD. Macrophage-specific expression of human lipoprotein lipase accelerates atherosclerosis in transgenic apolipoprotein e knockout mice but not in C57BL/6 mice. Arterioscler Thromb Vasc Biol 2001;21:1809-15.
23. Fyfe T, Baxter RH, Cochran KM, Booth EM. Plasma-lipid changes after myocardial infarction. Lancet 1971;2:997-1001.
24. McCall M, Elmfeldt D, Vedin A, Wilhelmsson C, Wedel H, Wilhelmsen L. Influence of a myocardial infarction on blood pressure and serum cholesterol. Acta Med Scand 1979;206:477-81.
25. Yang T, Pang CP, Tsang MW, Lam CW, Poon PM, Chan LY, et al. Pathogenic mutations of the lipoprotein lipase gene in Chinese patients with hypertriglyceridemic type 2 diabetes. Hum Mutat 2003;21:453.
26. Kontula K, Aalto-Setala K, Kuusi T, Hamalainen L, Syvanen AC. Apolipoprotein E polymorphism determined by restriction enzyme analysis of DNA amplified by polymerase chain reaction: convenient alternative to phenotyping by isoelectric focusing. Clin Chem 1990;36:2087-92.
27. Chen L, Baum L, Ng HK, Chan LY, Pang CP. Apolipoprotein E genotype and its pathological correlation in Chinese Alzheimer's disease with late onset. Hum Pathol 1999;30:1172-7.
28. Baroni MG, Berni A, Romeo S, Arca M, Tesorio T, Sorropago G, et al. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD. BCM Genet 2003;4:8.
29. Ferencak G, Pasalic D, Grskovic B, Cheng S, Fijal B, Sesto M, et al. Lipoprotein lipase gene polymorphisms in Croatian patients with coronary artery disease. Clin Chem Lab Med 2003;41:541-6.
30. Morrison AC, Ballantyne CM, Bray M, Chambless LE, Sharrett AR, Boerwinkle E. LPL polymorphism predicts stroke risk in men. Genet Epidemiol 2002;22:233-42.
31. van Bockxmeer FM, Liu Q, Mamotte C, Burke V, Taylor R. Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids. Atherosclerosis 2001;157:123-9.
32. Zhao SP, Tong QG, Xiao ZJ, Cheng YC, Zhou HN, Nie S. The lipoprotein lipase Ser447Ter mutation and risk of stroke in the Chinese. Clin Chim Acta 2003;330:161-4.
33. Napolitano M, Blotta I, Montali A, Bravo E. 17β-Estradiol enhances the flux of cholesterol through the cholesteryl ester cycle in human macrophages. Biosci Rep 2001;21:637-52.
34. Damewood MD, Bellantoni JJ, Bachorik PS, Kimball AW Jr, Rock JA. Exogenous estrogen effect on lipid/lipoprotein cholesterol in transsexual males. J Endocrinol Invest 1989;12:449-54.
35. Mullick AE, Deckelbaum RJ, Goldberg IJ, Al-Haideri M, Rutledge JC. Apolipoprotein E and lipoprotein lipase increase triglyceride-rich particle binding but decrease particle penetration in arterial wall. Arterioscler Thromb Vasc Biol 2002;22:2080-5.